Detailed Information on Publication Record
2023
Home-based cardio-oncology rehabilitation using a telerehabilitation platform in hematological cancer survivors: a feasibility study
FILAKOVA, Katerina, Andrea JANÍKOVÁ, Marián FELŠŐCI, Filip DOSBABA, Jing Jing SU et. al.Basic information
Original name
Home-based cardio-oncology rehabilitation using a telerehabilitation platform in hematological cancer survivors: a feasibility study
Authors
FILAKOVA, Katerina (203 Czech Republic), Andrea JANÍKOVÁ (203 Czech Republic), Marián FELŠŐCI (703 Slovakia), Filip DOSBABA (203 Czech Republic), Jing Jing SU, Garyfallia PEPERA and Ladislav BAŤALÍK (203 Czech Republic, guarantor, belonging to the institution)
Edition
BMC SPORTS SCIENCE MEDICINE AND REHABILITATION, LONDON, BMC, 2023, 2052-1847
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30304 Public and environmental health
Country of publisher
United Kingdom of Great Britain and Northern Ireland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 1.900 in 2022
RIV identification code
RIV/00216224:14110/23:00130650
Organization unit
Faculty of Medicine
UT WoS
000953040300002
Keywords in English
Cardio-oncology rehabilitation; Telerehabilitation; Home-based exercise; Cardiorespiratory fitness; Telemonitoring
Tags
International impact, Reviewed
Změněno: 31/1/2024 13:26, Mgr. Tereza Miškechová
Abstract
V originále
PurposeCardiovascular disease is a competing mortality cause in hematological cancer survivors due to toxic oncological treatment, accumulation of risk factors, and decline of cardiorespiratory fitness. Cardio-oncology rehabilitation (CORE) is an emerging treatment model to optimize the prognosis of hematological cancer patients and survivors; however, its accessibility during the COVID-19 pandemic is poor. The study aimed to evaluate the feasibility, safety, and effect of a 12-week home-based CORE intervention in telerehabilitation approach among hematological cancer survivors.MethodsA prospective single-arm interventional study was conducted at a faculty hospital in Brno, Czech Republic. This study provided 12 weeks of the home-based CORE using a telerehabilitation approach that allows remote supervision by a clinician from a medical facility. The telerehabilitation approach consists of three components: a heart rate sensor (PolarM430, Kempele, Finland), a web platform compatible with the sensor, and telesupervising via telephone call (1 call per week). To improve adherence, a physiotherapist called participants to assess or address adverse effects, exercise feedback, and participant-related concerns. The anthropometry, body composition, and cardiorespiratory fitness were measured immediately after the intervention.ResultsEleven hematological cancer survivors with an average age of 60.3 +/- 10 years participated in the study. Most participants were diagnosed with Follicular lymphoma and received maintenance treatment. Participants had a significant (p < 0.05) increase in cardiorespiratory fitness by 2.6 ml/kg/min; and in peak workload, from 143.3 +/- 60.6 W to 158.6 +/- 67.5 W (p < 0.05). Improvement in anthropometry and body composition was observed but yielded no statistical significance. Most (80%) participants completed the three times/per week telesupervising exercise session for 12 weeks.No adverse event was identified.ConclusionFindings from this study suggest that home-based CORE may provide hematological cancer survivors with an increase in CRF during the rehabilitation period after hospital discharge. The telerehabilitation CORE model is effective, feasible, safe, and has demonstrated good adherence. Further randomized controlled efficacy study with larger sample size is needed before clinical implementation.